Exploiting NK Cell Surveillance Pathways for Cancer Therapy
Natural killer (NK) cells can evoke potent anti-tumour activity. This function is largely mediated through a battery of specialised cell-surface receptors which probe the tissue microenvironment for changes in surface and secretory phenotypes that may alert to the presence of infection or malignancy...
Main Authors: | Alexander David Barrow, Marco Colonna |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/11/1/55 |
Similar Items
-
NK cell-based autologous immune enhancement therapy (AIET) for cancer (Invited Review)
by: Terunuma H, et al.
Published: (2013-04-01) -
Combination immune therapies to enhance anti-tumor responses by NK cells
by: Ashley Mentlik James, et al.
Published: (2013-12-01) -
Expression of a Recombinant High Affinity IgG Fc Receptor by Engineered NK Cells as a Docking Platform for Therapeutic mAbs to Target Cancer Cells
by: Kristin M. Snyder, et al.
Published: (2018-12-01) -
Natural killer cells for immunotherapy – Advantages of cell lines over blood NK cells
by: Hans eKlingemann, et al.
Published: (2016-03-01) -
Mechanisms of Resistance to NK Cell Immunotherapy
by: Christian Sordo-Bahamonde, et al.
Published: (2020-04-01)